Search for: "A. N. et al v. Pfizer, Inc. et al" Results 1 - 20 of 29
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Mar 2020, 1:32 pm by Noble McIntyre
Twelve Lots of CHANTIX® (Varenicline) Tablets have been recalled by Pfizer due to N-Nitroso Varenicline content above ADI level. [read post]
23 Jan 2020, 10:37 pm by Schachtman
The phosphodiesterases 5 inhibitor medications (PDE5i) seem to arouse the litigation propensities of the lawsuit industry. [read post]
16 Jul 2015, 4:00 am by Martin Kratz
Gould et al. (1983), 70 C.P.R. (2d) 11 (FCA). [read post]
25 Apr 2015, 11:03 am by Schachtman
See also Manual at 614 n. 198., citing Ofer Shpilberg, et al., The Next Stage: Molecular Epidemiology, 50 J. [read post]
14 Jun 2013, 12:13 pm by Schachtman
Wyeth, Inc., 686 F.3d 618, 622 n.5 (8th Cir. 2012), rev’g, In re Prempro Prods. [read post]
5 Jun 2013, 5:29 am by Schachtman
Oct. 24, 1996) Merrell Dow Pharms., Inc. v. [read post]
3 Mar 2012, 5:36 pm by Schachtman
Minn. 2008)(noting that some but not all courts have concluded relative risks under two support finding expert witness’s opinion to be inadmissible) XYZ, et al. v. [read post]
1 Feb 2012, 11:15 am by Sean Wajert
Abbott Laboratories, et al., No. 2:10-cv-03242 (E.D. [read post]
31 Aug 2010, 10:01 pm by Kelly
Apotex Inc. et al (Docket Report) Lovenox (Enoxaparin) – US: DC District Court denies preliminary injunction in generic Lovenox case; Is the juice worth the squeeze for Sanofi to appeal? [read post]